Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysis.

Respiratory Investigation
Akira KoaraiHisatoshi Sugiura

Abstract

In symptomatic COPD patients with a history of exacerbations, additional treatment with inhaled corticosteroid (ICS) to long-acting muscarinic antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy is recommended based on the evidence of low incidence of exacerbations but with a caution for pneumonia. However, ethnic differences may affect the response to drugs. Therefore, we conducted a systematic review and meta-analysis to evaluate the efficacy and safety of this treatment in the Japanese population (PROSPERO: CRD42020191978). We searched relevant randomized control trials and analyzed the exacerbations, quality of life, lung function, and adverse events including pneumonia and mortality as the outcomes of interest. We identified a total of three RCTs (N = 632). Treatment with ICS/LAMA/LABA triple therapy significantly decreased the exacerbations (rate ratio, 0.56; 95% CI, 0.38 to 0.85) and improved the trough FEV1 (mean difference, 0.04; 95% CI, 0.01 to 0.07) compared to LAMA/LABA therapy. However, triple therapy showed a significantly higher incidence of pneumonia compared to LAMA/LABA (odds ratio, 3.38; 95% CI, 1.58 to 7.22). Concerning other adverse events including mortality, there were no significant...Continue Reading

References

Apr 9, 2004·Lancet·Amy Berrington de González, Sarah Darby
Jul 11, 2008·Clinical Pharmacology and Therapeutics·S U YasudaS-M Huang
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Jan 5, 2011·Journal of Clinical Epidemiology·Gordon GuyattHolger J Schünemann
May 5, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yoshinosuke FukuchiDonald Tashkin
Jan 5, 2014·American Journal of Respiratory and Critical Care Medicine·Paul W JonesJadwiga A Wedzicha
May 18, 2016·The New England Journal of Medicine·Jadwiga A WedzichaUNKNOWN FLAME Investigators
Sep 30, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Masaharu Nishimura
Oct 28, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Shu HashimotoDonald Banerji
Feb 9, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Jadwiga A WedzichaDonald Banerji
Apr 19, 2018·The New England Journal of Medicine·David A LipsonUNKNOWN IMPACT Investigators
Jul 24, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Masakazu IchinoseMichiaki Mishima
Oct 13, 2018·The European Respiratory Journal·Mario CazzolaMaria Gabriella Matera
Dec 17, 2019·International Journal of Chronic Obstructive Pulmonary Disease·Motokazu KatoDavid A Lipson
May 1, 2020·BMC Pulmonary Medicine·Akira KoaraiMasakazu Ichinose
Jun 25, 2020·The New England Journal of Medicine·Klaus F RabeUNKNOWN ETHOS Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.